Identifying Bioproduction Challenges to Accelerate Therapies into the Clinic

Time: 4:30 pm
day: Day Two

Details:

• Addressing the advantages and disadvantages of ex vivo and in vivo manufacturing
• Overcoming current limitations when manufacturing vectors
• Adapting the corresponding quality control to fulfill regulatory agencies expectations

Speakers: